Literature DB >> 29526467

Unique predictors and economic burden of superficial and deep/organ space surgical site infections following pancreatectomy.

Ayòtúndé B Fadayomi1, Gyulnara G Kasumova1, Omidreza Tabatabaie1, Susanna W L de Geus1, Tara S Kent1, Sing Chau Ng1, A James Moser1, Mark P Callery1, Stanley W Ashley2, Jennifer F Tseng3.   

Abstract

BACKGROUND: Surgical site infections (SSIs) are common following pancreatectomy and associated with significant morbidity and economic burden. We sought to identify distinct predictors for superficial versus deep/organ space SSIs and their effects on surgical outcomes.
METHODS: ACS-NSQIP targeted pancreatectomy 2014 and 2015 databases were queried. Univariate and multivariate models were developed for both types of SSI, length of stay (LOS), and readmission. Costs were estimated based on Centers for Medicare & Medicaid Services (CMS) recommendations.
RESULTS: Of 8093 patients, there were 422 (5.2%) superficial and 1005 (12.4%) deep/organ space SSIs. On multivariate analyses, preoperative biliary stenting was predictive only for superficial SSI (OR: 2.21), while BMI of 25-29.9 (OR: 1.25) and BMI ≥30 kg/m2 (OR: 1.53), pancreatic duct size <3 mm (OR: 1.30), and intermediate (OR: 1.67) versus hard gland texture were predictors of deep/organ-space SSI. Superficial and deep/organ space SSIs were independent predictors of prolonged LOS (OR: 1.74 vs 1.80) and readmission (OR: 2.59 vs 6.57). Additional readmission costs per patient secondary to superficial SSI and deep/organ space SSI were $7661.37 and $18,409.42, respectively.
CONCLUSION: Deep/organ space SSI contributes more profoundly to prolonged hospital stay, readmission, and additional costs, suggesting that strategies should focus on preferential prevention of deep/organ space infections.
Copyright © 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29526467      PMCID: PMC6046258          DOI: 10.1016/j.hpb.2018.01.008

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  28 in total

1.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Am J Infect Control       Date:  1992-10       Impact factor: 2.918

2.  Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance?

Authors:  Paul J Speicher; Daniel P Nussbaum; John E Scarborough; Sabino Zani; Rebekah R White; Dan G Blazer; Christopher R Mantyh; Douglas S Tyler; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2014-05-23       Impact factor: 3.647

Review 3.  Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy.

Authors:  S P Povoski; M S Karpeh; K C Conlon; L H Blumgart; M F Brennan
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Differing risk factors for incisional and organ/space surgical site infections following abdominal colorectal surgery.

Authors:  Vanessa P Ho; Sharon L Stein; Koiana Trencheva; Philip S Barie; Jeffrey W Milsom; Sang W Lee; Toyooki Sonoda
Journal:  Dis Colon Rectum       Date:  2011-07       Impact factor: 4.585

5.  Clinicopathological parameters associated with surgical site infections in patients who underwent pancreatic resection.

Authors:  Atsushi Nanashima; Takafumi Abo; Junichi Arai; Shousaburo Oyama; Koji Mochinaga; Hirofumi Matsumoto; Katsunori Takagi; Masaki Kunizaki; Kazuo To; Hiroaki Takeshita; Shigekazu Hidaka; Takeshi Nagayasu
Journal:  Hepatogastroenterology       Date:  2014-09

6.  The effects of neoadjuvant chemoradiation on pancreaticoduodenectomy—the American College of Surgeon's National Surgical Quality Improvement Program analysis.

Authors:  Annabelle Teng; David Y Lee; Chun K Yang; Keith M Rose; Fadi Attiyeh
Journal:  J Surg Res       Date:  2015-01-30       Impact factor: 2.192

7.  Surgical site infections after colorectal surgery: do risk factors vary depending on the type of infection considered?

Authors:  Jennifer Blumetti; Myda Luu; George Sarosi; Kathleen Hartless; Jackie McFarlin; Betty Parker; Sean Dineen; Sergio Huerta; Massimo Asolati; Esteban Varela; Thomas Anthony
Journal:  Surgery       Date:  2007-11       Impact factor: 3.982

8.  Risk factor of surgical site infection after pancreaticoduodenectomy.

Authors:  Teiichi Sugiura; Katsuhiko Uesaka; Norio Ohmagari; Hideyuki Kanemoto; Takashi Mizuno
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

9.  Risk factors for superficial vs deep/organ-space surgical site infections: implications for quality improvement initiatives.

Authors:  Elise H Lawson; Bruce Lee Hall; Clifford Y Ko
Journal:  JAMA Surg       Date:  2013-09       Impact factor: 14.766

10.  Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy.

Authors:  Francesca Gavazzi; Cristina Ridolfi; Giovanni Capretti; Maria Rachele Angiolini; Paola Morelli; Erminia Casari; Marco Montorsi; Alessandro Zerbi
Journal:  BMC Gastroenterol       Date:  2016-03-31       Impact factor: 3.067

View more
  2 in total

1.  Impact of Bile Exposure Time on Organ/space Surgical Site Infections After Pancreaticoduodenectomy.

Authors:  Y U Kumagai; Shuichi Fujioka; Taigo Hata; Takeyuki Misawa; Hiroaki Kitamura; Kenei Furukawa; Yuichi Ishida; Katsuhiko Yanaga
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

2.  Surgical Site Infections and their economic significance in hepatopancreatobiliary surgery: A retrospective incidence, cost, and reimbursement analysis in a German centre of the highest level of care.

Authors:  Frank Werner Brennfleck; Tanja Bachmeier; Wolfgang Simet; Florian Zeman; Henrik Horst Gerhard Junger; Hans Jürgen Schlitt; Marc-Hendrik Dahlke; Stefan Martin Brunner
Journal:  Int Wound J       Date:  2020-10-02       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.